Cochrane Collaborative Review Group on peripheral vascular diseases: review abstract.

Abstract: Angioplasty (Versus Non-surgical distances did not show a greater improvement m the Management) for Intermittent Claudication angioplasty group. At 2 years of follow-up in one trial F.G.R. Fowkes and I.N. Gillespie the angioplasty group were more likely to have a Angioplasty (Versus Non-surgical distances did not show a greater improvement m the Management) for Intermittent Claudication angioplasty group. At 2 years of follow-up in one trial F.G.R. Fowkes and I.N. Gillespie the angioplasty group were more likely to have a Date of most recent substantive amendment: patent artery, OR 5.5 (95% CI 1.8, 17.0) but not a 19 February 1998 significantly better walking distance or quality of life. In the other trial, long-term follow-up at 6 years demonstrated no significant differences in outcome beObjectives tween the angioplasty and control groups. To determme if angioplasty of arteries in the leg is more effective than non-surgical therapy or no therapy Conclusions in patients with mild to moderate intermittent claudication. These limited results suggest that angloplasty may have had a short-term benefit, but this may not have been sustained. Further large scale trials are required. Meanwhile, widespread use of angioplasty for mild Search Strategy to moderate claudication cannot be recommended. Trials were identified using the search strategy of the Peripheral Vascular Diseases Review Group, reviewmg lists in papers and conference proceedings, and corresponding with selected authors. Abstract: Fixed dose subcutanous low molecular weight heparins versus adjusted dose unfractionated Selection Criteria heparin for venous thromboembolism A.G.M. van den Belt, M.H. Prins, A.W.A. Lensing, Trials were selected for inclusion by one reviewer and comprised only trials of mild or moderate interA.A. Castro, O.A.C. Clark, A.N. Atallah and mittent claudication in which patients were randomly E. Burihan allocated to angioplasty or conservative treatment. Date of most recent substantive amendment: Fixed dose subcutanous low molecular weight heparins versus adjusted dose unfractionated Selection Criteria heparin for venous thromboembolism A.G.M. van den Belt, M.H. Prins, A.W.A. Lensing, Trials were selected for inclusion by one reviewer and comprised only trials of mild or moderate interA.A. Castro, O.A.C. Clark, A.N. Atallah and mittent claudication in which patients were randomly E. Burihan allocated to angioplasty or conservative treatment. Date of most recent substantive amendment: Lesions amenable to angloplasty had to be dem14 January 1998 onstrated on angiography or duplex scanning.